TRDA – entrada therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Recent Price Trend in Entrada Therapeutics (TRDA) is Your Friend, Here's Why [Yahoo! Finance]
Entrada Therapeutics, Inc. (NASDAQ: TRDA) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Entrada Therapeutics, Inc. (NASDAQ: TRDA) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $29.00 price target on the stock.
Form 4 Entrada Therapeutics, For: Dec 10 Filed by: MPM BioVentures 2018 LLC
Form 4 Entrada Therapeutics, For: Dec 10 Filed by: MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Form 4 Entrada Therapeutics, For: Nov 29 Filed by: WENTWORTH KORY JAMES
Form 4 Entrada Therapeutics, For: Nov 29 Filed by: Sethuraman Natarajan
Form SC 13G/A Entrada Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.